Life sciences

#ABPI #ALS #Animal models #Cancer research #Covid-19 #Investment #Life sciences #MHRA #MND #mRNA-based vaccines

This week in Drug Discovery (10 – 14 November) 

News round-up for 10 – 14 November by Bruno Quinney, Content Team at DDW.  This week’s top story comes from groundbreaking research showing the Covid-19 mRNA vaccine boosts the immune system’s cancer response. The theme of UK investment dominates other headlines, while a report shows an effective… Read More

#News

#App note #Cell Science #Drug discovery #Life sciences #Live cell analysis #Spheroid

App Note: Go beyond 2D with 3D live-cell technologies

Boost your drug discovery with 3D spheroid models and live-cell analysis – perfect for screening thousands of compounds! A new App Note is now available from Sartorius entitled ‘Enhance Drug Discovery: Utilising a 3D Spheroid Model and Live-Cell Analysis for Compound Profiling’. Download the App Note to learn: How… Read More

#News

#App note #Cell Science #Drug discovery #Life sciences #Live cell analysis #Spheroid

Transform compound screening – Go beyond 2D with 3D live-cell technologies

Boost your drug discovery with 3D spheroid models and live-cell analysis – perfect for screening thousands of compounds! Download the App Note to learn: How to capture dynamic cellular changes in real time How to understand the advantages of 3D assays over traditional 2D models About advanced imaging and analysis… Read More

#App Notes #Resources

#Drug discovery #Life sciences #Lithuania

Agreement opens new pathways for Lithuanian life science scale-ups 

Innovation Agency Lithuania and AstraZeneca BioVentureHub (BVH) have signed a Memorandum of Understanding (MoU) at the Life Sciences Baltics 2025 event.   The agreement establishes a framework for collaboration aimed at assisting Lithuanian life science companies in engaging with BVH’s open innovation community in Gothenburg.   It… Read More

#Business & Investment #News

#AI #Drug development #Life sciences

State-of-the-art life sciences hub opened in London

Victoria House has been officially opened in London’s Bloomsbury Square as the capital’s state-of-the-art life sciences hub. The building was opened on Tuesday at a launch event which brought together leaders from science, academia, venture capital and the UK parliament. It is hoped Victoria House can help the UK achieve… Read More

#News

#Biopharma #Drug discovery #Life sciences #Start-ups

Pioneer and AbbVie team up on a Golden Ticket to accelerate human health 

Pioneer Group, a specialist in life science infrastructure and venture building, has again teamed up with biopharmaceutical company AbbVie to launch a Golden Ticket programme designed to accelerate companies developing novel, transformational therapies and innovations for immunology, oncology, neurology, eye care, aesthetics, or other specialities including obesity, GI and hepatology. Read More

#News

UK
#Financing #Investment #Life sciences #Start-ups #UK

Growing investor interest in later-stage UK life science companies

New research into the UK life sciences landscape has revealed a growing trend of investment into more mature companies.   Pioneer Group’s ‘Life Science Start Up Report’ also highlights a persistent regional imbalance, with ‘Golden Triangle’ university spinouts attracting significantly more funding than… Read More

#Business & Investment #News #Start-up Zone

#E3 ligases #Investment #Life sciences #Neurodegenerative disorders #TRIMTECH Therapeutics

Part 1: A day exploring Cambridge’s life science scene

DDW’s Megan Thomas went to Cambridge, UK, to learn more about what’s happening in this life science epicentre. She spoke with a number of local companies and attended events, the first of which she writes about here: A conversation with Nicola Thompson, CEO of TRIMTECH Therapeutics. E3 ligases to expand… Read More

#Business & Investment #Exclusive Content

#Artificial intelligence (AI) #Investment #Life sciences #NVIDIA #Sofinnova Partners #Start-ups

Collaboration to accelerate European life sciences startups

Sofinnova Partners, a European life sciences venture capital firm based in Paris, London, and Milan, has collaborated with NVIDIA to support its portfolio of life sciences startups. The collaboration delivers significant Graphics Processing Unit (GPU) credits to select Sofinnova portfolio companies, effectively giving access to the same computational… Read More

#Business & Investment #News #Start-up Zone

Fujifilm, California
#Business #Fujifilm Toyama Chemical #Life sciences

Fujifilm rebrands life sciences companies

FUJIFILM Irvine Scientific, headquartered in Santa Ana, California is to rebrand as FUJIFILM Biosciences as part of a new structure and strategy for the group.  FUJIFILM Corporation’s Life Sciences Group says the new names, collaborative strategic focus, and structural alignment reflects its commitment to life sciences. … Read More

#News

Cancer research lab
#Life sciences #Research and development #UK government #Wellcome Trust

UK data service promises to unlock health data for research

Wellcome has announced plans to partner with the UK Government to establish a new health data research service.  The new service, backed by £100 million from Wellcome and up to £500 million from the UK Government, will give approved researchers a single secure route to health data… Read More

#News

Downing Street, London, UK
#Funding #Life sciences #Research and development #UK #UK government

UK government commits £13.9 billion for R&D funding

The UK Department for Science, Innovation and Technology (DSIT) has set out how it will allocate £13.9 ($17.9) billion in funding for transformational research and development in the next year in areas like life sciences, green energy, engineering and beyond.   UK Research and Innovation (UKRI) – the… Read More

#News #Trending News